{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:58:53Z","timestamp":1782845933220,"version":"3.54.5"},"reference-count":11,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Dermatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Understanding the burden of various skin diseases can help guide funding allocation for skin disease research. A 2015 cross-sectional study found a partial correlation between US skin disease burden according to the 2010 Global Burden of Disease (GBD) study and National Institutes of Health (NIH) funding in 2012-2013.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to identify trends, correlations, and disparities in US skin disease burden and NIH research funding allocation using the latest data from the GBD 2021 and NIH funding data from the fiscal years 2021-2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional analysis was conducted to compare the disability-adjusted life years for 15 skin conditions from the GBD 2021 with NIH funding for these conditions in 2021-2022. Data were sourced from the GBD Results tool and the NIH RePORTER database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NIH funding for skin disease research and US skin disease burden according to the GBD 2021 were partially correlated, with several outliers. Malignant skin melanoma and pruritus were relatively overfunded, while psoriasis and urticaria were relatively underfunded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Disease burden is just one of the many important factors that must be considered when allocating resources, including funding to encourage research efforts to improve patient outcomes and positively impact public health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/71468","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T21:50:07Z","timestamp":1764885007000},"page":"e71468-e71468","source":"Crossref","is-referenced-by-count":0,"title":["Identifying Over- and Underfunded Diseases by Comparing National Institutes of Health Funding for Skin Disease Research With US Skin Disease Burden According to 2021 Global Burden of Disease Data: Cross-Sectional Analysis"],"prefix":"10.2196","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-1981","authenticated-orcid":false,"given":"Aileen","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2631-5551","authenticated-orcid":false,"given":"Emily","family":"Woolhiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2315-6166","authenticated-orcid":false,"given":"Hannah","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-4708","authenticated-orcid":false,"given":"Leo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4381-5635","authenticated-orcid":false,"given":"Haaris","family":"Kadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4580-5434","authenticated-orcid":false,"given":"Elizabeth","family":"Lamberty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4368-5638","authenticated-orcid":false,"given":"Parker","family":"Juels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4644-2854","authenticated-orcid":false,"given":"Sandra","family":"Jaroonwanichkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7239-0931","authenticated-orcid":false,"given":"Madison","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3334-0840","authenticated-orcid":false,"given":"Catherine","family":"Hegedus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1664-2496","authenticated-orcid":false,"given":"Dana","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7678-3496","authenticated-orcid":false,"given":"Danielle","family":"Duffle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-4816","authenticated-orcid":false,"given":"Jessica","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8669-8832","authenticated-orcid":false,"given":"Sydney","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-2999","authenticated-orcid":false,"given":"Emma","family":"Shelby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8132-088X","authenticated-orcid":false,"given":"Robert","family":"Dellavalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"R1","unstructured":"Institute for Health Metrics and Evaluation. Global Burden of Disease interactive data visuals. 2024. URL: https:\/\/vizhub.healthdata.org\/gbd-results [Accessed 16-12-2025]"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1145513","article-title":"The burden of skin and subcutaneous diseases: findings from the Global Burden Of Disease study 2019","volume":"11","author":"Yakupu","journal-title":"Front Public Health"},{"issue":"9859","key":"R3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","journal-title":"Lancet"},{"issue":"3","key":"R4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jaad.2015.04.039","article-title":"Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden","volume":"73","author":"Hagstrom","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jid.2020.05.089","article-title":"National Institutes of Health dermatology funding trends 2015-2019","volume":"141","author":"Price","journal-title":"J Invest Dermatol"},{"issue":"10","key":"R6","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.jid.2025.03.004","article-title":"National Institutes of Health dermatology funding trends: 2020-2024","volume":"145","author":"Joshi","journal-title":"J Invest Dermatol"},{"key":"R7","unstructured":"RePORTER. National Institutes of Health. URL: https:\/\/reporter.nih.gov\/advanced-search [Accessed 10-12-2025]"},{"key":"R8","unstructured":"Grants & funding. National Institutes of Health. URL: https:\/\/www.nih.gov\/grants-funding [Accessed 03-11-2024]"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Subramonian A Walter M . Newer Biologics for the Treatment Of Plaque Psoriasis. Canadian Agency for Drugs and Technologies in Health; 2021. URL: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585965\/ [Accessed 03-11-2024]","DOI":"10.51731\/cjht.2021.156"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2023.06.001","article-title":"Nonprofit funding in dermatology: a cross-sectional analysis in the United States, 2015 to 2019","volume":"12","author":"Agarwal","journal-title":"JAAD Int"},{"issue":"3","key":"R11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jaad.2022.06.1177","article-title":"Characterization of venture capital investments in dermatology: a cross-sectional analysis, 2011 to 2021","volume":"88","author":"Venkatesh","journal-title":"J Am Acad Dermatol"}],"container-title":["JMIR Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/derma.jmir.org\/2026\/1\/e71468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:00:51Z","timestamp":1782842451000},"score":1,"resource":{"primary":{"URL":"https:\/\/derma.jmir.org\/2026\/1\/e71468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2196\/71468","relation":{},"ISSN":["2562-0959"],"issn-type":[{"value":"2562-0959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"v9i9859e71468"}}